A recent meta-analysis evaluating 84 different studies regarding the association of 130 polymorphisms in 61 candidate genes in over 6,000 patients with severe COVID-19 and 8000 infected individuals with mild manifestations revealed a statistically significant association of ACE2 with the severity of COVID-19 [55]. The gene discussed is ACE2; the disease is COVID-19.